Product Information
OLOPATADINE 665 MCG NASAL SPRY is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.8991 per GM under NDC 45802010401. Its NADAC has been published 466 times since Jul 26, 2017.
Strength
665 ug/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802010401
Classification
Generic
Dosage Form
SPRAY
Route
NASAL
Last Updated
6/17/2026
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202853On Market Since
6/14/2017
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE 665 MCG NASAL SPRY has been published 466 times since Jul 26, 2017, and over the history we have for it it has declined 79.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8991 per GM |
|---|---|
| All-time high | $4.8968 (Sep 13, 2017) |
| All-time low | $0.7522 (May 22, 2024) |
| 52-week high | $1.0022 |
| 52-week low | $0.8568 |
| Median price | $1.4067 |
| Average price | $1.7250 |
| Largest weekly change | +49.7% (Feb 21, 2018) |
| Weeks tracked | 466 |
| Tracking since | Jul 26, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OLOPATADINE 665 MCG NASAL SPRY?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE 665 MCG NASAL SPRY, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.8991 per GM (NDC 45802010401), effective Jun 24, 2026.
How has the price of OLOPATADINE 665 MCG NASAL SPRY changed over time?
Over the history we have for it, the NADAC for OLOPATADINE 665 MCG NASAL SPRY has declined 79.5%. It has been tracked across 466 weekly CMS publications since Jul 26, 2017.
What are the highest and lowest recorded NADAC prices for OLOPATADINE 665 MCG NASAL SPRY?
Since Jul 26, 2017, the NADAC for OLOPATADINE 665 MCG NASAL SPRY has ranged from a low of $0.7522 (May 22, 2024) to a high of $4.8968 (Sep 13, 2017), with a median of $1.4067 per GM.
Are there cheaper alternatives to OLOPATADINE 665 MCG NASAL SPRY?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as OLOPATADINE 665 MCG NASAL SPRY, but none are currently priced below it.
Who manufactures OLOPATADINE 665 MCG NASAL SPRY?
OLOPATADINE 665 MCG NASAL SPRY (NDC 45802010401) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification